Green Cures Botanical Stock Last Dividend Paid
GRCU Stock | USD 0.0002 0.0001 100.00% |
Green Cures Botanical fundamentals help investors to digest information that contributes to Green Cures' financial success or failures. It also enables traders to predict the movement of Green Pink Sheet. The fundamental analysis module provides a way to measure Green Cures' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Green Cures pink sheet.
Green |
Green Cures Botanical Company Last Dividend Paid Analysis
Green Cures' Last Dividend Paid refers to dividend per share(DPS) paid to the shareholder the last time dividends were issued by a company. In its conventional sense, dividends refer to the distribution of some of a company's net earnings or capital gains decided by the board of directors.
More About Last Dividend Paid | All Equity Analysis
Last Dividend | = | Last Profit Distribution AmountTotal Shares |
Many stable companies today pay out dividends to their shareholders in the form of the income distribution, but high-growth firms rarely offer dividends because all of their earnings are reinvested back to the business.
Competition |
Based on the recorded statements, Green Cures Botanical has a Last Dividend Paid of 0.0. This indicator is about the same for the Healthcare average (which is currently at 0.0) sector and about the same as Drug Manufacturers—Specialty & Generic (which currently averages 0.0) industry. This indicator is about the same for all United States stocks average (which is currently at 0.0).
Did you try this?
Run Technical Analysis Now
Technical AnalysisCheck basic technical indicators and analysis based on most latest market data |
All Next | Launch Module |
Green Fundamentals
Return On Equity | 0.55 | |||
Return On Asset | 0.023 | |||
Profit Margin | 4.96 % | |||
Operating Margin | 0.62 % | |||
Current Valuation | 4.85 M | |||
Price To Sales | 2.80 X | |||
Revenue | 13.17 K | |||
Gross Profit | 989.6 K | |||
EBITDA | 861.7 K | |||
Net Income | (1.09 M) | |||
Cash And Equivalents | 80 K | |||
Cash Per Share | 0.04 X | |||
Total Debt | 3.1 M | |||
Debt To Equity | 0.09 % | |||
Current Ratio | 4.85 X | |||
Book Value Per Share | (2.23) X | |||
Cash Flow From Operations | (73.09 K) | |||
Earnings Per Share | 3.15 X | |||
Number Of Employees | 20 | |||
Beta | 1.09 | |||
Market Capitalization | 2.54 M | |||
Total Asset | 406 | |||
Retained Earnings | (1.58 M) | |||
Working Capital | (539 K) | |||
Current Liabilities | 539 K | |||
Z Score | -22.03 | |||
Net Asset | 406 |
About Green Cures Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Green Cures Botanical's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Green Cures using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Green Cures Botanical based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Green Pink Sheet Analysis
When running Green Cures' price analysis, check to measure Green Cures' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Green Cures is operating at the current time. Most of Green Cures' value examination focuses on studying past and present price action to predict the probability of Green Cures' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Green Cures' price. Additionally, you may evaluate how the addition of Green Cures to your portfolios can decrease your overall portfolio volatility.